Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EDIT | Editas Medicine, Inc. | Evp, Chief Financial Officer | $656K | -$125K | -16.1% | May 20, 2024 |
XAIR | Beyond Air, Inc. | Director | $17.3K | +$15.6K | +904% | Aug 14, 2024 |
AVEO | AVEO PHARMACEUTICALS, INC. | Chief Financial Officer | Jan 19, 2023 | |||
BBLG, BBLGW | Bone Biologics Corp | Director | Sep 18, 2023 | |||
SABS, SABSW | SAB Biotherapeutics, Inc. | Director | Jul 15, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|